Patiromer
Veltassa (patiromer) is a small molecule pharmaceutical. Patiromer was first approved as Veltassa on 2015-10-21. It is used to treat hyperkalemia in the USA. It has been approved in Europe to treat hyperkalemia. Veltassa's patents are valid until 2033-10-08 (FDA).
| Trade Name | Veltassa |
|---|---|
| Common Name | Patiromer |
| Indication | hyperkalemia |
| Drug Class | Polymers |
